Dysregulated Tissue Tensile Remodeling Following Surgical Trauma: Mechanisms, Clinical Implications, and Evidence-Based Management

Abstract

Dysregulated tissue tensile remodeling following surgical trauma is a clinically significant phenomenon that contributes to impaired wound healing, increased risk of complications, and long-term morbidity. This review synthesizes current evidence regarding the epidemiology, underlying mechanisms, risk factors, clinical manifestations, diagnostic challenges, and management strategies associated with aberrant tissue remodeling post-surgery. Emphasis is placed on integrating recent advances, guideline recommendations, and practical insights to inform clinical practice and optimize patient outcomes.

Introduction

Wound healing after surgical intervention is a complex, tightly regulated process involving coordinated cellular and extracellular matrix (ECM) responses that restore tissue integrity and tensile strength. However, in a subset of patients, this process becomes dysregulated, resulting in abnormal tensile remodeling. Such aberrations may manifest as hypertrophic scars, keloids, dehiscence, or pathological fibrosis, each of which can compromise function and aesthetic outcomes, and increase morbidity. Understanding the multifactorial etiology and pathophysiology of dysregulated tissue tensile remodeling is essential for the development of effective prevention and management strategies, particularly as surgical volumes increase globally.

Epidemiology / Disease Burden

The true incidence of dysregulated tensile remodeling is not precisely known, but studies suggest that up to 10–20% of surgical wounds may develop abnormal scarring or tensile properties. Disease burden is highest in high-tension anatomical regions, in patients undergoing repeated or complex interventions, and in those with comorbidities such as diabetes or connective tissue disorders. The sequelae of poor tensile remodeling include chronic pain, restricted mobility, cosmetic disfigurement, and increased healthcare utilization for revision procedures or prolonged care, underscoring the importance of early recognition and intervention.

Pathophysiology

Surgical trauma initiates a cascade of hemostatic, inflammatory, proliferative, and remodeling phases. Dysregulation can occur at any stage but is most deleterious during the remodeling phase, where matrix metalloproteinases (MMPs), fibroblasts, myofibroblasts, and transforming growth factor-beta (TGF-β) play pivotal roles. Excessive or prolonged TGF-β signaling, aberrant fibroblast activation, impaired collagen cross-linking, and imbalanced ECM turnover result in either weak, poorly organized scar tissue (predisposing to dehiscence) or excessive, contractile, and fibrotic tissue (leading to hypertrophic scarring and contractures). Recent evidence implicates mechanotransduction pathways, epigenetic modifications, and local tissue hypoxia as key modulators of tensile remodeling outcomes.

Risk Factors

Patient-specific risk factors include advanced age, diabetes mellitus, obesity, smoking, malnutrition, genetic predispositions (e.g., Ehlers-Danlos syndrome), and immunosuppression. Surgical factors such as wound location, tension on closure, technique, suture material, and presence of infection or hematoma significantly influence tensile remodeling. Systemic inflammation, delayed primary closure, and repeated trauma further exacerbate risk. Preoperative optimization and meticulous intraoperative technique are therefore critical in reducing adverse remodeling outcomes.

Clinical Features

Dysregulated remodeling may present as delayed wound healing, persistent erythema, abnormal firmness, excessive scar elevation, wound dehiscence, or contracture formation. On examination, affected tissues may demonstrate altered pliability, discoloration, or restricted movement. Chronic wounds may exhibit persistent exudate or ulceration, while hypertrophic or keloidal scars are often raised, pruritic, and extend beyond the original wound margins. Early identification of these features enables timely intervention and improved prognosis.

Diagnosis

Diagnosis is primarily clinical, supported by detailed history and physical examination. Objective assessment tools include tensiometry, ultrasound elastography, and high-resolution imaging to evaluate scar thickness, tissue elasticity, and vascularity. In select cases, biopsy may be warranted to exclude neoplastic transformation or infection. Emerging biomarkers such as circulating TGF-β, specific microRNAs, and ECM degradation products hold promise for early detection and risk stratification, though their routine use remains investigational.

Treatment & Management

Management strategies are tailored to the severity and type of remodeling abnormality. Non-pharmacological interventions include pressure garment therapy, silicone gel sheeting, and physical therapy for contractures. Pharmacologic options encompass topical and intralesional corticosteroids, 5-fluorouracil, and botulinum toxin A for scar modulation. Surgical revision may be necessary for refractory cases, particularly those with functional impairment or unacceptable cosmesis. Adjunctive therapies such as laser resurfacing, microneedling, and platelet-rich plasma (PRP) are increasingly utilized to enhance tissue remodeling and scar quality.

Recent Advances / Emerging Therapies

Recent advances have focused on targeted modulation of the wound microenvironment, including anti-TGF-β agents, angiotensin receptor blockers, and small molecule inhibitors of key fibrotic pathways. Stem cell-based therapies and biomaterial scaffolds offer promise in restoring physiological tensile properties via regenerative mechanisms. Gene editing approaches targeting fibrogenic genes and nanotechnology-based drug delivery systems are under active investigation. Early clinical trials of devices providing mechanical offloading and dynamic tissue tension adjustment show encouraging results in optimizing scar outcomes and tensile strength post-surgery.

Guideline Recommendations

Current clinical guidelines emphasize prevention as the cornerstone of management. Recommendations include meticulous surgical technique with minimal tissue trauma, tension-free closure, and appropriate selection of suture materials. Early mobilization, optimal wound care, and risk factor modification (e.g., glycemic control, smoking cessation) are strongly advocated. For established scars or contractures, stepwise escalation from non-invasive to invasive therapies is advised, with multidisciplinary involvement for complex cases. Ongoing research is needed to refine risk stratification algorithms and integrate novel therapies into standardized care pathways.

Conclusion

Dysregulated tissue tensile remodeling following surgical trauma represents a significant clinical challenge with implications for patient function, quality of life, and healthcare costs. Advances in understanding the molecular and biomechanical underpinnings have informed evidence-based interventions and emerging therapies. A multidisciplinary, individualized approach—grounded in prevention, early recognition, and judicious use of novel modalities—remains pivotal for optimizing wound healing and minimizing the burden of adverse remodeling outcomes.